STAT3 and colitis: We have previously shown that the CHGA-derived peptide, catestatin (CST; (hCHGA352–372), protects against the development of acute intestinal inflammation in two murine models of experimental colitis through modulation of pro-inflammatory macrophages function via a STAT3-dependent mechanism [17].